These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20957336)
1. CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda. Wickliffe JK; Abdel-Rahman SZ; Lee C; Kormos-Hallberg C; Sood G; Rondelli CM; Grady JJ; Desnick RJ; Anderson KE Mol Med; 2011; 17(3-4):241-7. PubMed ID: 20957336 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive cytochrome P450 CYP1A2 gene analysis in French caucasian patients with familial and sporadic porphyria cutanea tarda. Tchernitchko D; Robréau AM; Lefebvre T; Lamoril J; Deybach JC; Puy H Br J Dermatol; 2012 Feb; 166(2):425-9. PubMed ID: 21929532 [TBL] [Abstract][Full Text] [Related]
3. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda. Fontanellas A; Martínez-Fresno M; Garrido-Astray MC; Perucho T; Morán-Jiménez MJ; García-Bravo M; Méndez M; Poblete-Gutiérrez P; Frank J; Henriques-Gil N; de Salamanca RE Exp Dermatol; 2010 Aug; 19(8):e326-8. PubMed ID: 20163457 [TBL] [Abstract][Full Text] [Related]
4. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations. Weiss Y; Chen B; Yasuda M; Nazarenko I; Anderson KE; Desnick RJ Mol Genet Metab; 2019 Nov; 128(3):363-366. PubMed ID: 30514647 [TBL] [Abstract][Full Text] [Related]
5. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Christiansen L; Bygum A; Jensen A; Thomsen K; Brandrup F; Hørder M; Petersen NE Hum Genet; 2000 Dec; 107(6):612-4. PubMed ID: 11153915 [TBL] [Abstract][Full Text] [Related]
6. Uroporphyria in the Cyp1a2-/- mouse. Phillips JD; Kushner JP; Bergonia HA; Franklin MR Blood Cells Mol Dis; 2011 Dec; 47(4):249-54. PubMed ID: 21880518 [TBL] [Abstract][Full Text] [Related]
7. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242 [TBL] [Abstract][Full Text] [Related]
8. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients. Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123 [TBL] [Abstract][Full Text] [Related]
9. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study. Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803 [TBL] [Abstract][Full Text] [Related]